Get startedLog in
    Picture of Recursion Pharmaceuticals logo

    RXRX — Recursion Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Recursion Pharmaceuticals Inc First Patient Has Been Dosed In Its Phase 2 Clinical Trial Of Rec-3964

    Picture of Recursion Pharmaceuticals logoRecursion Pharmaceuticals
    22/10/2024 14:39
    Oct 22 (Reuters) - Recursion Pharmaceuticals Inc
 RXRX.O :
    * RECURSION PHARMACEUTICALS INC: FIRST PATIENT HAS BEEN
DOSED IN
ITS PHASE 2 CLINICAL TRIAL OF REC-3964

Source text for Eikon:  ID:nGNEbwR97z 
Further company coverage:  RXRX.O 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Recursion Pharmaceuticals

    See all news